Agrenvec Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Out of Business
Agrenvec General Information
Description
Operator of a biotechnology company intended to specialize in plant production of mammalian recombinant proteins and antibodies for the R&D market. The company's recombinant proteins, clean antibodies, and mini-blot easy kits are produced in a 100% animal-free non-transgenic-plant system, enabling customers to increase protein expression levels and reducing purification costs.
Contact Information
Website
www.agrenvec.esCorporate Office
- C/Santiago Grisolia 2, D132
- PCM Tres Cantos
- 28760 Madrid
- Spain
Corporate Office
- C/Santiago Grisolia 2, D132
- PCM Tres Cantos
- 28760 Madrid
- Spain
Agrenvec Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 26-Mar-2022 | Completed | Out of Business | |||
| 3. Secondary Transaction - Private | Completed | Startup | ||||
| 2. Early Stage VC | 01-Mar-2014 | Completed | Startup | |||
| 1. Grant | Completed | Startup |
Agrenvec Signals
Agrenvec FAQs
-
When was Agrenvec founded?
Agrenvec was founded in 2002.
-
Where is Agrenvec headquartered?
Agrenvec is headquartered in Madrid, Spain.
-
What is the size of Agrenvec?
Agrenvec has 9 total employees.
-
What industry is Agrenvec in?
Agrenvec’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Agrenvec a private or public company?
Agrenvec is a Private company.
-
What is Agrenvec’s current revenue?
The current revenue for Agrenvec is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process